Search - tctmd.com

Displaying 21 - 40 of 289

Sort: Relevancy | Date

News Conference News EuroPCR 2019

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

Michael O'Riordan

May 27, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Daily News

Many PCI Patients Treated in China Have No Angina Symptoms

Caitlin E. Cox

December 20, 2018

News Daily News

Debate Over BMS vs DES in High-Bleeding-Risk Scenarios Gets Fresh Fuel in Meta-analysis

Yael L. Maxwell

November 05, 2018

News Daily News

Another Observational Study Supports Role for Genotype-Guided Antiplatelet Choices Post-PCI

Yael L. Maxwell

April 04, 2018

Presentation ACC 2018

6-Month versus 12-Month or Longer Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome (SMART-DATE)

Presenter: Hyeon-Cheol Gwon

March 12, 2018

Presentation ACC 2018

A Pragmatic Randomized Trial of CYP2C19 Genotyping Implementation Following Percutaneous Coronary Intervention (PCI)

Presenter: Sony Tuteja

March 12, 2018

News Industry News

Baxter Announces U.S. FDA Approval of Ready-to-Use Cardiovascular Medication Bivalirudin

January 22, 2018

News Opinion Editor's Corner ESC 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Shelley Wood

August 18, 2017

News Industry News

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

August 15, 2017

News Daily News

More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis

Michael O'Riordan

July 03, 2017

News Daily News

STEMI Patients Far From PCI Centers Fare Well With Pharmacoinvasive Strategy

L.A. McKeown

October 05, 2016

News Conference News ESC 2016

Prasugrel, Ticagrelor Give Similar Short-term Outcomes After Primary PCI: PRAGUE-18

Todd Neale

August 30, 2016

News Daily News

冠脉内阿昔单抗显示对糖尿病 STEMI 患者有优势

L.A. McKeown

August 11, 2016

News Daily News

El Abciximab Intracoronario es Beneficioso en Pacientes Diabéticos Víctimas de STEMI

L.A. McKeown

August 11, 2016

News Daily News

Adherence to Guideline-Based Acute MI Therapies Has Prolonged Impact on Mortality Rates

Michael O'Riordan

May 17, 2016

News Conference News SCAI 2016

Bleeding Calculator Use Linked to Dramatic Decrease in Post-PCI Bleeding

L.A. McKeown

May 05, 2016

News Daily News

深入调查发现 PCI 中的出血规避策略对结局影响不大

Yael L. Maxwell

April 25, 2016

News Daily News

Un Análisis Certero de Estrategias para la Evitación de Hemorragias en PCI Revela Poco Impacto en los Resultados

Yael L. Maxwell

April 25, 2016

News Conference News ACC 2016

Meta-analysis Delves Into Bivalirudin Versus Heparin Debate in Primary PCI

Yael L. Maxwell

April 04, 2016

Advertisement

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Many PCI Patients Treated in China Have No Angina Symptoms

Debate Over BMS vs DES in High-Bleeding-Risk Scenarios Gets Fresh Fuel in Meta-analysis

Another Observational Study Supports Role for Genotype-Guided Antiplatelet Choices Post-PCI

6-Month versus 12-Month or Longer Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome (SMART-DATE)

A Pragmatic Randomized Trial of CYP2C19 Genotyping Implementation Following Percutaneous Coronary Intervention (PCI)

Baxter Announces U.S. FDA Approval of Ready-to-Use Cardiovascular Medication Bivalirudin

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis

STEMI Patients Far From PCI Centers Fare Well With Pharmacoinvasive Strategy

Prasugrel, Ticagrelor Give Similar Short-term Outcomes After Primary PCI: PRAGUE-18

冠脉内阿昔单抗显示对糖尿病 STEMI 患者有优势

El Abciximab Intracoronario es Beneficioso en Pacientes Diabéticos Víctimas de STEMI

Adherence to Guideline-Based Acute MI Therapies Has Prolonged Impact on Mortality Rates

Bleeding Calculator Use Linked to Dramatic Decrease in Post-PCI Bleeding

深入调查发现 PCI 中的出血规避策略对结局影响不大

Un Análisis Certero de Estrategias para la Evitación de Hemorragias en PCI Revela Poco Impacto en los Resultados

Meta-analysis Delves Into Bivalirudin Versus Heparin Debate in Primary PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content